ROYALTY PHARMA PLC shareholders Q3 2023

ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 312 filers reported holding ROYALTY PHARMA PLC in Q3 2023. The put-call ratio across all filers is 0.16 and the average weighting 0.3%.

ROYALTY PHARMA PLC shareholders Q3 2023
NameSharesValueWeighting ↓
Siguler Guff Advisers, LLC 3,391,754$92,052,20447.04%
Indie Asset Partners, LLC 433,000$11,751,62011.84%
SUVRETTA CAPITAL MANAGEMENT, LLC 4,095,745$111,158,5196.01%
Advanced Portfolio Management, LLC 230,000$6,242,2005.25%
Compound Global Advisors, LLC 626,412$17,000,8223.73%
Geo Capital Gestora de Recursos Ltd 135,079$3,6663.39%
TORRAY INVESTMENT PARTNERS LLC 412,633$11,198,8601.98%
Overbrook Management Corp 298,712$8,107,0441.89%
Silicon Valley Community Foundation 358,270$9,723,4481.18%
Greytown Advisors Inc. 74,601$2,024,6711.12%
Vantage Consulting Group Inc 57,500$1,560,5501.05%
VIKING GLOBAL INVESTORS LP 9,464,201$256,858,4151.04%
HOMESTEAD ADVISERS CORP 1,343,040$36,450,1061.01%
GMT CAPITAL CORP 929,700$25,232,0580.95%
MYCIO WEALTH PARTNERS, LLC 113,652$3,084,5160.92%
Lagoda Investment Management, L.P. 38,930$1,056,5600.69%
Aurora Investment Counsel 37,902$1,028,6610.68%
Marathon Asset Management Ltd 765,833$20,784,7080.64%
GENERAL ATLANTIC, L.P. 1,500,000$40,710,0000.63%
ADAGE CAPITAL PARTNERS GP, L.L.C. 9,840,000$267,057,6000.61%
External links

This page lists ROYALTY PHARMA PLC's shareholders in Q3 2023. To view ROYALTY PHARMA PLC's shareholder history, click here.